O. Civelli, R.K. Reinscheid, Y. Zhang, Z. Wang, R. Fredriksson, and H.B. Schioth G protein-coupled receptor deorphanizations Annu. Rev. Pharmacol. Toxicol. 53 2013 127 146
A.P. Davenport, S.P. Alexander, J.L. Sharman, A.J. Pawson, H.E. Benson, A.E. Monaghan, and et al. International union of basic and clinical pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands Pharmacol. Rev. 65 2013 967 986
A.C. Magalhaes, H. Dunn, and S.S. Ferguson Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins Br. J. Pharmacol. 165 2012 1717 1736
N. Wettschureck, and S. Offermanns Mammalian G proteins and their cell type specific functions Physiol. Rev. 85 2005 1159 1204
T. Kenakin Functional selectivity and biased receptor signaling J. Pharmacol. Exp. Ther. 336 2011 296 302
C. Williams cAMP detection methods in HTS: selecting the best from the rest Nat. Rev. Drug Discov. 3 2004 125 135
C.Z. Chen, N. Southall, J. Xiao, J.J. Marugan, M. Ferrer, X. Hu, and et al. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay J. Biomol. Screen. 18 2013 670 677
S. Titus, S. Neumann, W. Zheng, N. Southall, S. Michael, C. Klumpp, and et al. Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor J. Biomol. Screen. 13 2008 120 127
M.D. Houslay, and G. Milligan Tailoring cAMP-signalling responses through isoform multiplicity Trends Biochem. Sci. 22 1997 217 224
K.B. Seamon, W. Padgett, and J.W. Daly Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells Proc. Natl. Acad. Sci. U. S. A. 78 1981 3363 3367
Y. Wang, Y. Kong, G.J. Shei, L. Kang, and M.E. Cvijic Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells Assay Drug Dev. Technol. 9 2011 522 531
S.J. Hill, C. Williams, and L.T. May Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies Br. J. Pharmacol. 161 2010 1266 1275
F. Fan, B.F. Binkowski, B.L. Butler, P.F. Stecha, M.K. Lewis, and K.V. Wood Novel genetically encoded biosensors using firefly luciferase ACS Chem. Biol. 3 2008 346 351
T. Wittenberger, H.C. Schaller, and S. Hellebrand An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors J. Mol. Biol. 307 2001 799 813
W. He, F.J. Miao, D.C. Lin, R.T. Schwandner, Z. Wang, J. Gao, and et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors Nature 429 2004 188 193
I. Toma, J.J. Kang, A. Sipos, S. Vargas, E. Bansal, F. Hanner, and et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney J. Clin. Invest. 118 2008 2526 2534
T. Rubic, G. Lametschwandtner, S. Jost, S. Hinteregger, J. Kund, N. Carballido-Perrig, and et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity Nat. Immunol. 9 2008 1261 1269
P. Sapieha, M. Sirinyan, D. Hamel, K. Zaniolo, J.S. Joyal, J.H. Cho, and et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis Nat. Med. 14 2008 1067 1076
N. Sadagopan, W. Li, S.L. Roberds, T. Major, G.M. Preston, Y. Yu, and et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease Am. J. Hypertens. 20 2007 1209 1215
P.R. Correa, E.A. Kruglov, M. Thompson, M.F. Leite, J.A. Dranoff, and M.H. Nathanson Succinate is a paracrine signal for liver damage J. Hepatol. 47 2007 262 269
C. Hogberg, O. Gidlof, C. Tan, S. Svensson, J. Nilsson-Ohman, D. Erlinge, and et al. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-beta signaling J. Thromb. Haemost. 9 2011 361 372
B. Spath, A. Hansen, C. Bokemeyer, and F. Langer Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists Platelets 23 2012 60 68
D. Bhuniya, D. Umrani, B. Dave, D. Salunke, G. Kukreja, J. Gundu, and et al. Discovery of a potent and selective small molecule hGPR91 antagonist Bioorg. Med. Chem. Lett. 21 2011 3596 3602
H. Takakura, M. Hattori, M. Takeuchi, and T. Ozawa Visualization and quantitative analysis of G protein-coupled receptor-beta-arrestin interaction in single cells and specific organs of living mice using split luciferase complementation ACS Chem. Biol. 7 2012 901 910
J. Hanson, N. Ferreiros, B. Pirotte, G. Geisslinger, and S. Offermanns Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A(4) Biochem. Pharmacol. 85 2013 1795 1802
J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73
V.V. Gurevich, and E.V. Gurevich The structural basis of arrestin-mediated regulation of G-protein-coupled receptors Pharmacol. Ther. 110 2006 465 502
C. Southern, J.M. Cook, Z. Neetoo-Isseljee, D.L. Taylor, C.A. Kettleborough, A. Merritt, and et al. Screening beta-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors J. Biomol. Screen. 18 2013 599 609
B.K. Atwood, J. Lopez, J. Wager-Miller, K. Mackie, and A. Straiker Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis BMC Genomics 12 2011 14
C.C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382 1996 829 833
C.G. Wermuth Selective optimization of side activities: the SOSA approach Drug Discov. Today 11 2006 160 164
M.T. Klein, M. Dukat, R.A. Glennon, and M. Teitler Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships J. Pharmacol. Exp. Ther. 337 2011 860 867
C.W. Scott, and M.F. Peters Label-free whole-cell assays: expanding the scope of GPCR screening Drug Discov. Today 15 2010 704 716
T.P. Kenakin Cellular assays as portals to seven-transmembrane receptor-based drug discovery Nat. Rev. Drug Discov. 8 2009 617 626
S.B. Liggett, N.J. Freedman, D.A. Schwinn, and R.J. Lefkowitz Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor Proc. Natl. Acad. Sci. U. S. A. 90 1993 3665 3669
W. Cao, L.M. Luttrell, A.V. Medvedev, K.L. Pierce, K.W. Daniel, T.M. Dixon, and et al. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation J. Biol. Chem. 275 2000 38131 38134
G.E. Callander, W.G. Thomas, and R.A. Bathgate Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment Am. J. Physiol. Cell Physiol. 296 2009 C1058 66
S. Al-Sabah, M. Al-Fulaij, G. Shaaban, H.A. Ahmed, R.J. Mann, D. Donnelly, and et al. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively PLoS One 9 2014 e106890
S. Rajagopal, J. Kim, S. Ahn, S. Craig, C.M. Lam, N.P. Gerard, and et al. Beta-arrestin- but not G protein-mediated signaling by the decoy receptor CXCR7 Proc. Natl. Acad. Sci. U. S. A. 107 2010 628 632
W. de Lau, N. Barker, T.Y. Low, B.K. Koo, V.S. Li, H. Teunissen, and et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling Nature 476 2011 293 297
L. Sundstrom, P.J. Greasley, S. Engberg, M. Wallander, and E. Ryberg Succinate receptor GPR91, a Galpha(i) coupled receptor that increases intracellular calcium concentrations through PLCbeta FEBS Lett. 587 2013 2399 2404
C. Harrison, and J.R. Traynor The [35S]GTPgammaS binding assay: approaches and applications in pharmacology Life Sci. 74 2003 489 508
E. Kostenis, M. Waelbroeck, and G. Milligan Techniques: promiscuous Galpha proteins in basic research and drug discovery Trends Pharmacol. Sci. 26 2005 595 602
J. Pantel, S.Y. Williams, D. Mi, J. Sebag, J.D. Corbin, C.D. Weaver, and et al. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay Eur. J. Pharmacol. 660 2011 139 147
R. Irannejad, J.C. Tomshine, J.R. Tomshine, M. Chevalier, J.P. Mahoney, J. Steyaert, and et al. Conformational biosensors reveal GPCR signalling from endosomes Nature 495 2013 534 538
B.F. Binkowski, B.L. Butler, P.F. Stecha, C.T. Eggers, P. Otto, K. Zimmerman, and et al. A luminescent biosensor with increased dynamic range for intracellular cAMP ACS Chem. Biol. 6 2011 1193 1197
S.P. Brothers, S.A. Saldanha, T.P. Spicer, M. Cameron, B.A. Mercer, P. Chase, and et al. Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening Mol. Pharmacol. 77 2010 46 57
P.A. Insel, and R.S. Ostrom Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling Cell. Mol. Neurobiol. 23 2003 305 314
J.R. Jasper, M.C. Michel, and P.A. Insel Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists Mol. Pharmacol. 37 1990 44 49
